TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

BioRegenx, Inc. (OTC: BRGX) Announces Major Corporate Progress, Auditor Transition, Technology Integration, and AI-Driven Strategic Vision

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bill Resides (Ceo)
BioRegenx, Inc. (OTC: BRGX) Announces Major Corporate Progress, Auditor Transition, Technology Integration, and AI-Driven Strategic Vision

BioRegenx has finalized a license for GlycoCheck® diagnostic platform, completed DocSun AI acquisition, and engaged a new auditor. The company aims to integrate microvascular diagnostics with AI analytics to provide early health insights.

Insights
BRGX   positive

Company demonstrated strategic progress through technology integration, new partnerships, auditor transition, and clear vision for AI-driven health analytics